Unknown

Dataset Information

Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.


ABSTRACT: Identification of agents that target human leukemia stem cells is an important consideration for the development of new therapies. The present study demonstrates that rocaglamide and silvestrol, closely related natural products from the flavagline class of compounds, are able to preferentially kill functionally defined leukemia stem cells, while sparing normal stem and progenitor cells. In addition to efficacy as single agents, flavaglines sensitize leukemia cells to several anticancer compounds, including front-line chemotherapeutic drugs used to treat leukemia patients. Mechanistic studies indicate that flavaglines strongly inhibit protein synthesis, leading to the reduction of short-lived antiapoptotic proteins. Notably though, treatment with flavaglines, alone or in combination with ot

SUBMITTER: Callahan KP 

PROVIDER: S-EPMC4148474 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature